Comparison of the antiremodeling effects of losartan and mirabegron in a rat model of uremic cardiomyopathyZsuzsanna Z. A. Kovács(University of Szeged), Márta Sárközy(University of Szeged)Scientific ReportsSeptember 1, 202110.1038/s41598-021-96815-5Cited by 26SaveCiteExport RISWatch citationsRelated PapersRole of the kisspeptin-KISS1R axis in the pathogenesis of chronic kidney disease and uremic cardiomyopathy|GeroScience|2023|11The kisspeptin-1 receptor antagonist peptide-234 aggravates uremic cardiomyopathy in a rat model|Scientific Reports|2023|5Comparison of the antiremodeling effects of losartan and mirabegron in a rat model of uremic cardiomyopathy|Unknown|2021|1